EquitySector - HealthcareVery High Risk
Direct
NAV (17-Apr-25)
Returns (Since Inception)
Fund Size
₹370 Cr
Expense Ratio
0.78%
ISIN
INF966L01CD0
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
18 Jul 2023
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+6.68%
+17.55% (Cat Avg.)
Since Inception
+24.26%
— (Cat Avg.)
Equity | ₹367.71 Cr | 99.40% |
Others | ₹2.23 Cr | 0.60% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Divi's Laboratories Ltd | Equity | ₹35.4 Cr | 9.57% |
RPG Life Sciences Ltd | Equity | ₹34.34 Cr | 9.28% |
Aster DM Healthcare Ltd Ordinary Shares | Equity | ₹34.09 Cr | 9.22% |
Ipca Laboratories Ltd | Equity | ₹27.45 Cr | 7.42% |
Torrent Pharmaceuticals Ltd | Equity | ₹27.04 Cr | 7.31% |
Alivus Life Sciences Ltd | Equity | ₹26.63 Cr | 7.20% |
Zydus Lifesciences Ltd | Equity | ₹25.97 Cr | 7.02% |
Aurobindo Pharma Ltd | Equity | ₹25.22 Cr | 6.82% |
Reliance Industries Ltd | Equity | ₹24.76 Cr | 6.69% |
Zydus Wellness Ltd | Equity | ₹21.57 Cr | 5.83% |
Pfizer Ltd | Equity | ₹19.31 Cr | 5.22% |
HFCL Ltd | Equity | ₹18.9 Cr | 5.11% |
Sequent Scientific Ltd | Equity | ₹17.61 Cr | 4.76% |
SMS Pharmaceuticals Ltd | Equity | ₹14.08 Cr | 3.81% |
Nca-Net Current Assets | Cash - Collateral | ₹-10.18 Cr | 2.75% |
91 Days Tbill Red 24-04-2025 | Bond - Gov't/Treasury | ₹9.95 Cr | 2.69% |
Suraksha Diagnostic Ltd | Equity | ₹8.82 Cr | 2.38% |
Dr. Reddy's Laboratories Limited 24/04/2025 | Equity - Future | ₹4.31 Cr | 1.16% |
Treps 02-Apr-2025 Depo 10 | Cash - Repurchase Agreement | ₹2.46 Cr | 0.66% |
Aurobindo Pharma Limited 24/04/2025 | Equity - Future | ₹2.18 Cr | 0.59% |
Large Cap Stocks
30.59%
Mid Cap Stocks
14.24%
Small Cap Stocks
52.81%
AAA
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹295.98 Cr | 80.01% |
Energy | ₹24.76 Cr | 6.69% |
Consumer Defensive | ₹21.57 Cr | 5.83% |
Technology | ₹18.9 Cr | 5.11% |
Standard Deviation
This fund
--
Cat. avg.
16.77%
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
0.75
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
1.30
Higher the better
Since July 2023
Since July 2023
Since July 2023
Since January 2025
Since March 2025
Since February 2025
Since March 2025
ISIN INF966L01CD0 | Expense Ratio 0.78% | Exit Load 1.00% | Fund Size ₹370 Cr | Age 1 year 9 months | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty Healthcare TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Fund name | Expense Ratio | Exit Load | Fund size | 1Y |
---|---|---|---|---|
Bajaj Finserv Healthcare Fund Regular Growth Very High Risk | 2.4% | 1.0% | ₹307.40 Cr | - |
Bajaj Finserv Healthcare Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹307.40 Cr | - |
PGIM India Healthcare Fund Direct Growth Very High Risk | 0.7% | 0.0% | ₹104.18 Cr | - |
PGIM India Healthcare Fund Regular Growth Very High Risk | 2.4% | 0.0% | ₹104.18 Cr | - |
WhiteOak Capital Pharma and Healthcare Fund Regular Growth Very High Risk | 2.4% | 1.0% | ₹303.62 Cr | 26.8% |
WhiteOak Capital Pharma and Healthcare Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹303.62 Cr | 29.0% |
DSP Nifty Healthcare ETF Regular Growth Very High Risk | 0.2% | - | ₹9.77 Cr | 15.8% |
Kotak Healthcare Fund Direct Growth Very High Risk | 0.8% | 0.0% | ₹411.54 Cr | 16.3% |
Kotak Healthcare Fund Regular Growth Very High Risk | 2.4% | 0.0% | ₹411.54 Cr | 14.4% |
HDFC Pharma and Healthcare Fund Regular Growth Very High Risk | 2.1% | 1.0% | ₹1634.08 Cr | 27.7% |
Total AUM
₹84,056 Cr
Address
A.M. Road, Prabhadevi, Mumbai, 400025
Fund name | Expense Ratio | Exit Load | Fund size | 1Y |
---|---|---|---|---|
Quant Commodities Fund Direct Growth Very High Risk | 1.1% | 1.0% | ₹368.02 Cr | 4.6% |
Quant Momentum Fund Direct Growth Very High Risk | 0.9% | 1.0% | ₹1671.54 Cr | -1.7% |
Quantum Small Cap Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹108.01 Cr | 6.8% |
Quant Teck Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹373.03 Cr | -0.7% |
360 ONE Quant Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹631.71 Cr | 11.4% |
Quant Value Fund Direct Growth Very High Risk | 0.4% | 1.0% | ₹1674.71 Cr | -4.9% |
Nippon India Quant Fund Direct Growth Very High Risk | 0.4% | 0.0% | ₹92.16 Cr | 9.2% |
Quant BFSI Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹560.08 Cr | -0.9% |
quant Healthcare Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹369.93 Cr | 6.7% |
DSP Quant Fund Direct Growth Very High Risk | 0.6% | 0.0% | ₹976.05 Cr | 5.9% |
ICICI Prudential Quant Fund Direct Growth Very High Risk | 1.2% | 1.0% | ₹124.89 Cr | 13.0% |
Axis Quant Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹940.51 Cr | -1.9% |
Quant Quantamental Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹1891.54 Cr | -6.2% |
Tata Quant Fund Direct Growth Very High Risk | 0.9% | 1.0% | ₹61.70 Cr | 8.5% |
Quant Focused fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹1013.18 Cr | -3.8% |
Quant Large and Mid Cap Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹3518.89 Cr | -2.5% |
Quant Active Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹9389.39 Cr | -6.5% |
Quant Small Cap Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹24892.62 Cr | -1.8% |
Quant Absolute Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹2000.44 Cr | -0.6% |
Quant Infrastructure Fund Direct Growth Very High Risk | 0.8% | 0.0% | ₹3158.34 Cr | -10.2% |
Quant Multi Asset Fund Direct Growth High Risk | 0.6% | 1.0% | ₹3182.56 Cr | 4.6% |
Quant Flexi Cap Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹6712.15 Cr | -1.8% |
Quant Tax Plan Direct Growth Very High Risk | 0.5% | 0.0% | ₹10404.84 Cr | -6.6% |
Quant Liquid Plan Direct Growth Moderate Risk | 0.3% | 0.0% | ₹1536.26 Cr | 7.3% |
Quant Mid Cap Fund Direct Growth Very High Risk | 0.6% | 0.0% | ₹8355.95 Cr | -3.2% |
Quant Gilt Fund Direct Growth Moderate Risk | 0.5% | 0.0% | ₹124.84 Cr | 10.0% |
Quant Manufacturing Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹826.48 Cr | -2.7% |
Quant Business Cycle Fund Direct Growth Very High Risk | 0.5% | 1.0% | ₹1237.93 Cr | -2.0% |
Quant ESG Equity Fund Direct Growth Very High Risk | 0.9% | 1.0% | ₹277.36 Cr | 2.1% |
Quant Overnight Fund Direct Growth Low Risk | 0.2% | 0.0% | ₹139.18 Cr | 6.7% |
Quant Large Cap Fund Direct Growth Very High Risk | 0.4% | 1.0% | ₹2434.44 Cr | -3.2% |
Quant Dynamic Asset Allocation Fund Direct Growth High Risk | 0.7% | 1.0% | ₹1199.42 Cr | -0.1% |
Your principal amount will be at Very High Risk
EquitySector - HealthcareVery High Risk
Direct
NAV (17-Apr-25)
Returns (Since Inception)
Fund Size
₹370 Cr
Expense Ratio
0.78%
ISIN
INF966L01CD0
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
18 Jul 2023
Your principal amount will be at Very High Risk
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+6.68%
+17.55% (Cat Avg.)
Since Inception
+24.26%
— (Cat Avg.)
Equity | ₹367.71 Cr | 99.40% |
Others | ₹2.23 Cr | 0.60% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Divi's Laboratories Ltd | Equity | ₹35.4 Cr | 9.57% |
RPG Life Sciences Ltd | Equity | ₹34.34 Cr | 9.28% |
Aster DM Healthcare Ltd Ordinary Shares | Equity | ₹34.09 Cr | 9.22% |
Ipca Laboratories Ltd | Equity | ₹27.45 Cr | 7.42% |
Torrent Pharmaceuticals Ltd | Equity | ₹27.04 Cr | 7.31% |
Alivus Life Sciences Ltd | Equity | ₹26.63 Cr | 7.20% |
Zydus Lifesciences Ltd | Equity | ₹25.97 Cr | 7.02% |
Aurobindo Pharma Ltd | Equity | ₹25.22 Cr | 6.82% |
Reliance Industries Ltd | Equity | ₹24.76 Cr | 6.69% |
Zydus Wellness Ltd | Equity | ₹21.57 Cr | 5.83% |
Pfizer Ltd | Equity | ₹19.31 Cr | 5.22% |
HFCL Ltd | Equity | ₹18.9 Cr | 5.11% |
Sequent Scientific Ltd | Equity | ₹17.61 Cr | 4.76% |
SMS Pharmaceuticals Ltd | Equity | ₹14.08 Cr | 3.81% |
Nca-Net Current Assets | Cash - Collateral | ₹-10.18 Cr | 2.75% |
91 Days Tbill Red 24-04-2025 | Bond - Gov't/Treasury | ₹9.95 Cr | 2.69% |
Suraksha Diagnostic Ltd | Equity | ₹8.82 Cr | 2.38% |
Dr. Reddy's Laboratories Limited 24/04/2025 | Equity - Future | ₹4.31 Cr | 1.16% |
Treps 02-Apr-2025 Depo 10 | Cash - Repurchase Agreement | ₹2.46 Cr | 0.66% |
Aurobindo Pharma Limited 24/04/2025 | Equity - Future | ₹2.18 Cr | 0.59% |
Large Cap Stocks
30.59%
Mid Cap Stocks
14.24%
Small Cap Stocks
52.81%
AAA
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹295.98 Cr | 80.01% |
Energy | ₹24.76 Cr | 6.69% |
Consumer Defensive | ₹21.57 Cr | 5.83% |
Technology | ₹18.9 Cr | 5.11% |
Standard Deviation
This fund
--
Cat. avg.
16.77%
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
0.75
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
1.30
Higher the better
Since July 2023
Since July 2023
Since July 2023
Since January 2025
Since March 2025
Since February 2025
Since March 2025
ISIN INF966L01CD0 | Expense Ratio 0.78% | Exit Load 1.00% | Fund Size ₹370 Cr | Age 1 year 9 months | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty Healthcare TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Fund name | Expense Ratio | Exit Load | Fund size | 1Y |
---|---|---|---|---|
Bajaj Finserv Healthcare Fund Regular Growth Very High Risk | 2.4% | 1.0% | ₹307.40 Cr | - |
Bajaj Finserv Healthcare Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹307.40 Cr | - |
PGIM India Healthcare Fund Direct Growth Very High Risk | 0.7% | 0.0% | ₹104.18 Cr | - |
PGIM India Healthcare Fund Regular Growth Very High Risk | 2.4% | 0.0% | ₹104.18 Cr | - |
WhiteOak Capital Pharma and Healthcare Fund Regular Growth Very High Risk | 2.4% | 1.0% | ₹303.62 Cr | 26.8% |
WhiteOak Capital Pharma and Healthcare Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹303.62 Cr | 29.0% |
DSP Nifty Healthcare ETF Regular Growth Very High Risk | 0.2% | - | ₹9.77 Cr | 15.8% |
Kotak Healthcare Fund Direct Growth Very High Risk | 0.8% | 0.0% | ₹411.54 Cr | 16.3% |
Kotak Healthcare Fund Regular Growth Very High Risk | 2.4% | 0.0% | ₹411.54 Cr | 14.4% |
HDFC Pharma and Healthcare Fund Regular Growth Very High Risk | 2.1% | 1.0% | ₹1634.08 Cr | 27.7% |
Total AUM
₹84,056 Cr
Address
A.M. Road, Prabhadevi, Mumbai, 400025
Fund name | Expense Ratio | Exit Load | Fund size | 1Y |
---|---|---|---|---|
Quant Commodities Fund Direct Growth Very High Risk | 1.1% | 1.0% | ₹368.02 Cr | 4.6% |
Quant Momentum Fund Direct Growth Very High Risk | 0.9% | 1.0% | ₹1671.54 Cr | -1.7% |
Quantum Small Cap Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹108.01 Cr | 6.8% |
Quant Teck Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹373.03 Cr | -0.7% |
360 ONE Quant Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹631.71 Cr | 11.4% |
Quant Value Fund Direct Growth Very High Risk | 0.4% | 1.0% | ₹1674.71 Cr | -4.9% |
Nippon India Quant Fund Direct Growth Very High Risk | 0.4% | 0.0% | ₹92.16 Cr | 9.2% |
Quant BFSI Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹560.08 Cr | -0.9% |
quant Healthcare Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹369.93 Cr | 6.7% |
DSP Quant Fund Direct Growth Very High Risk | 0.6% | 0.0% | ₹976.05 Cr | 5.9% |
ICICI Prudential Quant Fund Direct Growth Very High Risk | 1.2% | 1.0% | ₹124.89 Cr | 13.0% |
Axis Quant Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹940.51 Cr | -1.9% |
Quant Quantamental Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹1891.54 Cr | -6.2% |
Tata Quant Fund Direct Growth Very High Risk | 0.9% | 1.0% | ₹61.70 Cr | 8.5% |
Quant Focused fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹1013.18 Cr | -3.8% |
Quant Large and Mid Cap Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹3518.89 Cr | -2.5% |
Quant Active Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹9389.39 Cr | -6.5% |
Quant Small Cap Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹24892.62 Cr | -1.8% |
Quant Absolute Fund Direct Growth Very High Risk | 0.7% | 1.0% | ₹2000.44 Cr | -0.6% |
Quant Infrastructure Fund Direct Growth Very High Risk | 0.8% | 0.0% | ₹3158.34 Cr | -10.2% |
Quant Multi Asset Fund Direct Growth High Risk | 0.6% | 1.0% | ₹3182.56 Cr | 4.6% |
Quant Flexi Cap Fund Direct Growth Very High Risk | 0.6% | 1.0% | ₹6712.15 Cr | -1.8% |
Quant Tax Plan Direct Growth Very High Risk | 0.5% | 0.0% | ₹10404.84 Cr | -6.6% |
Quant Liquid Plan Direct Growth Moderate Risk | 0.3% | 0.0% | ₹1536.26 Cr | 7.3% |
Quant Mid Cap Fund Direct Growth Very High Risk | 0.6% | 0.0% | ₹8355.95 Cr | -3.2% |
Quant Gilt Fund Direct Growth Moderate Risk | 0.5% | 0.0% | ₹124.84 Cr | 10.0% |
Quant Manufacturing Fund Direct Growth Very High Risk | 0.8% | 1.0% | ₹826.48 Cr | -2.7% |
Quant Business Cycle Fund Direct Growth Very High Risk | 0.5% | 1.0% | ₹1237.93 Cr | -2.0% |
Quant ESG Equity Fund Direct Growth Very High Risk | 0.9% | 1.0% | ₹277.36 Cr | 2.1% |
Quant Overnight Fund Direct Growth Low Risk | 0.2% | 0.0% | ₹139.18 Cr | 6.7% |
Quant Large Cap Fund Direct Growth Very High Risk | 0.4% | 1.0% | ₹2434.44 Cr | -3.2% |
Quant Dynamic Asset Allocation Fund Direct Growth High Risk | 0.7% | 1.0% | ₹1199.42 Cr | -0.1% |
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments